Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
1.790
+0.060 (3.47%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Skye Bioscience Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 68.42 | 1.26 | 1.24 | 8.98 | 2.47 | Upgrade
|
| Short-Term Investments | - | - | 0.07 | - | - | Upgrade
|
| Cash & Short-Term Investments | 68.42 | 1.26 | 1.32 | 8.98 | 2.47 | Upgrade
|
| Cash Growth | 5345.15% | -4.72% | -85.32% | 263.77% | 34.94% | Upgrade
|
| Other Receivables | 0.01 | 0.7 | 0.18 | - | - | Upgrade
|
| Receivables | 0.01 | 0.7 | 0.18 | - | - | Upgrade
|
| Prepaid Expenses | 0.2 | 0.19 | 0.78 | 0.57 | 0.19 | Upgrade
|
| Restricted Cash | - | 9.08 | 0 | 0 | 0 | Upgrade
|
| Other Current Assets | 2.2 | 0.42 | 6.66 | 0.06 | 0 | Upgrade
|
| Total Current Assets | 70.83 | 11.65 | 8.94 | 9.61 | 2.66 | Upgrade
|
| Property, Plant & Equipment | 1.88 | 0.28 | 0.16 | 0.23 | 0.01 | Upgrade
|
| Other Long-Term Assets | 0.05 | 0.01 | 0.01 | 0.01 | - | Upgrade
|
| Total Assets | 72.76 | 11.94 | 9.11 | 9.86 | 2.67 | Upgrade
|
| Accounts Payable | 0.57 | 0.96 | 1.79 | 0.9 | 0.36 | Upgrade
|
| Accrued Expenses | 1.77 | 2.06 | 1.12 | 0.9 | 0.32 | Upgrade
|
| Short-Term Debt | - | 4.37 | 0.06 | - | - | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 1.85 | 1.97 | 0.06 | Upgrade
|
| Current Portion of Leases | 0.18 | 0.07 | 0.08 | 0.08 | - | Upgrade
|
| Other Current Liabilities | 1.82 | 6.44 | 7.22 | 0.06 | 0.04 | Upgrade
|
| Total Current Liabilities | 4.34 | 13.9 | 12.12 | 3.91 | 0.79 | Upgrade
|
| Long-Term Debt | - | - | - | - | 1.43 | Upgrade
|
| Long-Term Leases | 0.27 | 0.17 | - | 0.08 | - | Upgrade
|
| Total Liabilities | 4.61 | 14.07 | 12.12 | 3.99 | 2.22 | Upgrade
|
| Common Stock | 0.03 | 0.01 | 0 | 0.48 | 0.29 | Upgrade
|
| Additional Paid-In Capital | 199.07 | 102.24 | 63.73 | 52.64 | 38.9 | Upgrade
|
| Retained Earnings | -130.95 | -104.38 | -66.74 | -47.26 | -38.73 | Upgrade
|
| Total Common Equity | 68.15 | -2.13 | -3.01 | 5.86 | 0.45 | Upgrade
|
| Shareholders' Equity | 68.15 | -2.13 | -3.01 | 5.86 | 0.45 | Upgrade
|
| Total Liabilities & Equity | 72.76 | 11.94 | 9.11 | 9.86 | 2.67 | Upgrade
|
| Total Debt | 0.46 | 4.62 | 1.98 | 2.14 | 1.5 | Upgrade
|
| Net Cash (Debt) | 67.96 | -3.36 | -0.66 | 6.85 | 0.97 | Upgrade
|
| Net Cash Growth | - | - | - | 604.71% | -32.66% | Upgrade
|
| Net Cash Per Share | 1.86 | -0.48 | -0.30 | 4.21 | 1.05 | Upgrade
|
| Filing Date Shares Outstanding | 30.97 | 28.06 | 3.89 | 1.98 | 1.4 | Upgrade
|
| Total Common Shares Outstanding | 30.97 | 12.35 | 3.65 | 1.9 | 1.15 | Upgrade
|
| Working Capital | 66.49 | -2.25 | -3.18 | 5.7 | 1.88 | Upgrade
|
| Book Value Per Share | 2.20 | -0.17 | -0.82 | 3.08 | 0.39 | Upgrade
|
| Tangible Book Value | 68.15 | -2.13 | -3.01 | 5.86 | 0.45 | Upgrade
|
| Tangible Book Value Per Share | 2.20 | -0.17 | -0.82 | 3.08 | 0.39 | Upgrade
|
| Machinery | 1.64 | 0.12 | - | - | - | Upgrade
|
| Leasehold Improvements | 0.02 | 0.01 | - | - | - | Upgrade
|
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.